Search Ontology:
ChEBI
dasatinib monohydrate
- Term ID
- CHEBI:70839
- Synonyms
-
- BMS 354825-03
- BMS 35482503
- dasatinib
- dasatinib hydrate
- dasatinib.H2O
- N-(2-chloro-6-methylphenyl)-2-((6-(4-(2- hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide hydrate
- N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide--water (1/1)
- Sprycel
- Definition
- A hydrate that is the monohydrate of dasatinib. It is used for the treatment of chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia. Note that the name 'dasatinib' is used to refer to the monohydrate (USAN) as well as to anhydrous dasatinib (INN).
- References
-
- CAS:863127-77-9
- KEGG:D06414
- PMID:18223208
- PMID:19749489
- PMID:21226671
- PMID:22233429
- Patent:WO2005077945
- Patent:WO2010067374
- Patent:WO2010139979
- Patent:WO2010139980
- Patent:WO2011095059
- Reaxys:14444783
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_part
-
- has_role
-
Phenotype
Phenotype resulting from dasatinib monohydrate
Phenotype where environments contain dasatinib monohydrate
Phenotype modified by environments containing dasatinib monohydrate
Human Disease Model